传记
Dr. David Kain is Lead Investor Relations at GentleFill, where he leads strategic investor outreach, partnership development, and capital raising to advance the company through clinical validation and regulatory approval. He serves as a scientific advisor to the company, bringing over 15 years of experience in medical research, preclinical development, and translational innovation. Dr. Kain holds a PhD in Medical Research and has worked extensively across cardiovascular science, neuroscience, oncology, and medical device development, bridging rigorous science with commercial execution.
